Sam Brusco, Associate Editor09.28.22
Johnson & Johnson Vision has earned U.S. Food and Drug Administration (FDA) approval for an expanded range of its AcuVue Ability overnight therapeutic lenses for myopia management, up to 6 diopters (previously, 4 diopters).
The company also announced greater availability of the lenses nationwide at this year’s Vision By Design myopia control and management meeting.
“By expanding the parameters for Abiliti Overnight lenses, it creates more opportunities for eye care professionals to reach even more patients,” sChandra Mickles, OD, MS, FAAO, FSLS, North America Professional Education Lead, Myopia, Johnson & Johnson Vision, told the press. “The expansion of treatment options comes at a critical time as myopia rates continue to rise among children. At Johnson & Johnson Vision, we remain committed to changing the trajectory of myopia with evidence-based strategies and professional support.”
The orthokeratology (ortho-k) lenses are worn overnight to temporarily lower refractive error, and in conjunction with a myopia management plan can remove the need for contacts or glasses during the day after the lenses are removed. The lenses are designed to match the eye based on its unique corneal shape and prescription.
J&J Vision’s FitAbiliti software guides the eye care professional through the fitting process and recommends a lens.
“Myopia is on the rise and it is critical to meet increasing patient needs with innovative solutions,” said Nicholas Despotidis, OD, FAAO, FCOVD, FAAOMC. “With this new expansion of Abiliti Overnight lenses, optometrists are now able to provide additional treatment options to even more myopic patients. Getting the fitting right as efficiently as possible is important and I’ve found great success and ease-of-use with the FitAbiliti software.”
The company also announced greater availability of the lenses nationwide at this year’s Vision By Design myopia control and management meeting.
“By expanding the parameters for Abiliti Overnight lenses, it creates more opportunities for eye care professionals to reach even more patients,” sChandra Mickles, OD, MS, FAAO, FSLS, North America Professional Education Lead, Myopia, Johnson & Johnson Vision, told the press. “The expansion of treatment options comes at a critical time as myopia rates continue to rise among children. At Johnson & Johnson Vision, we remain committed to changing the trajectory of myopia with evidence-based strategies and professional support.”
The orthokeratology (ortho-k) lenses are worn overnight to temporarily lower refractive error, and in conjunction with a myopia management plan can remove the need for contacts or glasses during the day after the lenses are removed. The lenses are designed to match the eye based on its unique corneal shape and prescription.
J&J Vision’s FitAbiliti software guides the eye care professional through the fitting process and recommends a lens.
“Myopia is on the rise and it is critical to meet increasing patient needs with innovative solutions,” said Nicholas Despotidis, OD, FAAO, FCOVD, FAAOMC. “With this new expansion of Abiliti Overnight lenses, optometrists are now able to provide additional treatment options to even more myopic patients. Getting the fitting right as efficiently as possible is important and I’ve found great success and ease-of-use with the FitAbiliti software.”